<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154681">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01865591</url>
  </required_header>
  <id_info>
    <org_study_id>SITV-CL-0001</org_study_id>
    <nct_id>NCT01865591</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Renal Denervation for the Treatment of Resistant Hypertension</brief_title>
  <acronym>SoundITV</acronym>
  <official_title>A Clinical Trial for the Assessment of Safety and Efficacy of the UltraSOUND Mediated InTerVentional Treatment of Resistant Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sound Interventions, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sound Interventions, Inc.</source>
  <oversight_info>
    <authority>Czech Republic: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the potential therapeutic benefit of catheter-based renal
      sympathetic denervation using therapeutic unfocussed ultrasound in a single-arm feasibility
      trial.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>Phase 0</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Major adverse events</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>All cause death, renal artery occlusion, renal artery stenosis, renal infarction and/or renal failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in office blood pressure measurement</measure>
    <time_frame>30 days, 3 months, 6 months, 9 months, 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in ambulatory 24-hour blood pressure measurement</measure>
    <time_frame>6 months, 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in renal artery dimensions</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Change in renal artery dimensions as measured by renal angiography, CT, or MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in creatinine</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events and device complications</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Uncontrolled Hypertension</condition>
  <arm_group>
    <arm_group_label>Renal denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects are treated with unfocussed ultrasound-based renal denervation and are maintained on baseline anti-hypertensive medications.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound-based Renal Denervation</intervention_name>
    <arm_group_label>Renal denervation</arm_group_label>
    <other_name>Sound TX System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uncontrolled hypertension (defined as SBP ≥ 140 mmHg during 24Hr Ambulatory BP
             monitoring)

          -  Current treatment with ≥ 3 anti-hypertensive drugs (including at least one diuretic)

          -  Renal artery diameter ≥5mm by digital angiography

          -  Accessibility of renal vasculature

        Exclusion Criteria:

          -  Estimated GFR &lt; 45

          -  Type 1 Diabetes

          -  Known renovascular abnormalities (eg, renal artery stenosis, previous renal artery
             stenting or angioplasty)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David A. Smith</last_name>
    <email>dsmith@sounditv.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Na Homolce Hospital</name>
      <address>
        <city>Prague</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Coling</last_name>
      <email>liz.coling@homolka.cz</email>
    </contact>
    <investigator>
      <last_name>Petr Neuzil, MD PhD FESC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 30, 2013</lastchanged_date>
  <firstreceived_date>May 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>uncontrolled hypertension</keyword>
  <keyword>resistant hypertension</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
